JOHN BEDELL: Open Payments
NPI 1528254570 · ISLAND PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 36 payments from 15 companies in 2025. Trend: 2023 $905 · 2024 $2,034 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $194 |
| ABBVIE INC. | 12 | $162 |
| Amgen Inc. | 7 | $125 |
| Novo Nordisk Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: BREZTRI, OTEZLA, AIRSUPRA, UBRELVY, LINZESS, Ozempic, QULIPTA, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
